The Conflicts of Interest statement in the article, ‘Considerations in reporting palliative care clinical trials: standardizing information reported and authorship practices,’ which published in the December 2012 issue of the journal, was stated incorrectly .
The correct Conflicts of Interest statement should read as follows:
Conflicts of interest
Disclosures/conflicts: This work was supported in part by a grant from the National Institute of Nursing Research (NINR GRANT UC4-NR12584). Dr A.P.A. has research funding from the US National Institutes of Health, US Agency for Healthcare Research and Quality, Robert Wood Johnson Foundation, BioVex, DARA, Helsinn, MiCo and Pfizer; these funds are all distributed to Duke University Medical Center to support research including salary support for A.P.A. In the last 2 years, she has had nominal consulting agreements with or received honoraria from (<US$5000 annually) Novartis and Pfizer. Consulting with Bristol Meyers Squibb is pending in 2012, for role as Co-Chair of a Scientific Advisory Committee.
J.S.K. has research funding from the US National Institutes of Health and US Agency for Healthcare Research and Quality and is a Medical Editor for the Foundation for Informed Medical Decision Making.
The other authors have no disclosures or conflicts to declare.
1. LeBlanc TW, Abernethy AP, Currow DC, Kutner JS. Considerations in reporting palliative care clinical trials: standardizing information reported and authorship practices. Curr Opin Support Palliat Care 2012; 6:494–499.